Boardroom Alpha
Start trial
8-K primary document
NNDM · Current Report (Form 8-K) · Filed July 21, 2026

Nano Dimension Ltd — 8-K exhibit

nndm-ex99_1.htm
Nano Dimension Ltd on Boardroom Alpha
EX-99.1

Exhibit 99.1

Nano Dimension Continues Execution of Cost Savings Initiatives

 

Enters into Agreement to Terminate Current Corporate Headquarters Lease, Expected to Generate Approximately $25 Million in Cumulative Net Cash Savings

 

Waltham, Massachusetts, July 17, 2026 – Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) today announced that it has entered into an agreement to terminate the lease for its current corporate headquarters, effective December 31, 2026.

 

As part of its ongoing cost savings initiatives, the current management team successfully negotiated the termination of the long-term lease, originally entered into by MarkForged, Inc. in 2021 and scheduled to expire in 2031, substantially reducing the Company's future lease obligations.

 

The Company previously disclosed that the sale of MarkForged, Inc. was expected to reduce annualized cash burn by approximately $15 million. This estimate included approximately $7.5 million of annualized lease-related cost savings associated with the corporate headquarters lease.

 

Through the termination of the lease, Nano Dimension expects to eliminate approximately $38 million of cumulative future lease costs through 2031. After accounting for the approximately $13 million lease termination payment, the Company expects to realize approximately $25 million of cumulative net cash savings.

 

This transaction reflects management’s disciplined approach to capital allocation and demonstrates its continued focus on streamlining operations, reducing cash burn and strengthening the Company’s financial position.

 

About Nano Dimension Ltd.

 

Nano Dimension Ltd. (Nasdaq: NNDM) has historically delivered advanced digital manufacturing technologies, including serving customers across the defense, aerospace, automotive, electronics and medical device industry segments. For more information, please visit www.nano-di.com.

 

Contacts:

Investors: Purva Sanariya
Director, Investor Relations
ir@nano-di.com

 

Media: Samuel Manning
Principal Manager, External Communications
press@nano-di.com

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer